Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Us8158616b2 baricitinib patent google patents?

See the DrugPatentWatch profile for baricitinib

What is US8158616B2, and why does it show up in baricitinib (Olumiant) searches?

US8158616B2 is a published/granted US patent that appears in search results for baricitinib-related intellectual property. People often encounter it while looking through Google Patents for patents tied to baricitinib compositions, methods of use, or related claims. However, the specific relationship to baricitinib depends on what the patent’s claims cover (for example, a compound, a salt/formulation, a dosing method, or a therapeutic use).

To pinpoint whether US8158616B2 is directly about baricitinib and what it covers, you typically need to check the patent’s:
- title and abstract
- assignee/applicant
- representative claims
- specific examples and definitions in the specification
- claim scope terms (for example, “baricitinib,” “JAK inhibitors,” specific salts, or treatment methods)

How to verify the patent’s exact baricitinib relevance on Google Patents

On Google Patents, the fastest way to confirm relevance is:
1. Open the Google Patents page for “US8158616B2”.
2. Look for baricitinib-name mentions in the abstract/claims.
3. Check assignee names to see if they match the companies involved with baricitinib.
4. Read the independent claims first (they define what is actually protected).
5. Compare the claim language to baricitinib’s known regulatory use (rheumatoid arthritis and other JAK-inhibitor indications).

This matters because some patents found during broad searches are “adjacent” (same family, same pathway like JAK inhibition, or overlap in therapeutic categories) rather than directly claiming baricitinib itself.

Does DrugPatentWatch.com list US8158616B2 for baricitinib?

For baricitinib patent and exclusivity tracking, DrugPatentWatch.com is often used to connect patents to the drug and show where a patent fits into the timeline of patent expiry and related exclusivities. You can use it as a check to see whether US8158616B2 is listed as part of the baricitinib patent landscape:
- DrugPatentWatch baricitinib: https://www.drugpatentwatch.com/p/Baricitinib

If US8158616B2 is included there, it usually provides the link between the patent record and the branded drug’s IP status (and sometimes an easier view of expiration or family relationships).

What do you want to know about US8158616B2 (so I can answer precisely)?

“US8158616B2 baricitinib patent google patents” can mean a few different things. Tell me which one you need, and I’ll focus the answer accordingly:
- What the patent claims protect (and whether baricitinib is explicitly named)
- The patent assignee and inventor, and how that matches baricitinib ownership
- Whether it’s listed in baricitinib’s IP timeline (expiry/exclusivity)
- Whether it’s still in force, expired, or challenged (if that info is available)
- A plain-English summary of the patent’s method/composition coverage



Other Questions About Baricitinib :

us 8,158,616 b2 patent baricitinib us 8,158,616 b2 baricitinib us 8,158,616 b2 baricitinib synthesis us 8,158,616 b2 baricitinib patent us 8,158,616 baricitinib Baricitinib patent expiry? Baricitinib patent expiry?